Webinar

Transforming biomarker development Thumbnail

Transforming Biomarker Development for Cancer Immunotherapy: Introducing the PhenoCode Signature Approach

As cancer treatment evolves with the advent of new immunotherapies, it is crucial to accurately identify which patients will respond to these treatments. The tumor microenvironment (TME) has been shown to be a key factor in determining therapeutic responses across various cancer types.

Transforming Biomarker Development for Cancer Immunotherapy: Introducing the PhenoCode Signature Approach Read More »